RecruitingNCT07767227

Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic Cysts

Pilot Proof of Concept Study of miRNA and Protein Signatures in Exosomes From Blood and Cystic Fluid in Patients Undergoing Surgery for Worrisome Pancreatic Cysts


Sponsor

Translational Genomics Research Institute

Enrollment

30 participants

Start Date

Feb 3, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to collect biospecimens (blood and cystic fluid) and data from participants who have a pancreatic cyst that requires surgical resection. The blood and fluid samples will be analyzed for research into DNA, RNA, and proteins.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with pancreatic cyst. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Hoag Family Cancer Institute

Newport Beach, California, United States

Piedmont HealthCare

Atlanta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07767227


Related Trials